Written by: Marc Adler, Esq., Director of Compliance Consulting
While I am sure your organization has been primarily focused on efforts to comply with the federal "Sunshine" law as well as filing the Vermont and/or West Virginia disclosure reports, our Compliance Services team wanted to share with you some of the noteworthy aggregate spend bills proposed in 2013 (so far).
The Massachusetts legislature has proposed amendments that focus on the new quarterly, "non-CME educational presentation" reports enacted into law last year. Unfortunately for the life sciences industry, however, just as companies were starting to think that the Massachusetts requirements would become less strict, the proposed changes would impose additional burden. Specifically, bills in the Massachusetts House and Senate, which are now under consideration by the Joint Committee on Public Health, contain the following proposed changes: